Australia markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.46-0.29 (-1.84%)
At close: 04:00PM EDT
15.80 +0.34 (+2.20%)
After hours: 07:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
14,018
0
0
0
Operating expenses
Research development
23,405
23,089
23,272
14,110
7,486
Selling general and administrative
13,553
19,657
13,629
11,094
4,775
Total operating expenses
36,958
42,746
36,901
25,204
12,261
Operating income or loss
-36,958
-28,728
-36,901
-25,204
-12,261
Interest expense
-
-
-
10
38
Total other income/expenses net
-80,802
-80,802
-
503
-5,538
Income before tax
-36,962
-106,806
-36,896
-24,711
-17,837
Income from continuing operations
-36,962
-106,806
-36,896
-24,711
-17,837
Net income
-36,962
-106,806
-36,896
-24,711
-17,837
Net income available to common shareholders
-37,584
-106,806
-37,518
-24,711
-17,837
Basic EPS
-1.80
-
-3.09
-2.14
-5.26
Diluted EPS
-1.80
-
-3.09
-2.14
-5.26
Basic average shares
12,178
-
12,127
11,539
3,390
Diluted average shares
12,178
-
12,127
11,539
3,390